Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

NCT01193088 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1050

Last updated 2025-10-07

No results posted yet for this study

Summary

This project includes two projects. One is looking for new genes that cause Charcot Marie Tooth disease (CMT). The other is looking for genes that do not cause CMT, but may modify the symptoms a person has.

Conditions

  • Charcot-Marie-Tooth Disease, Type Ia (Disorder)
  • HMSN

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • Muscular Dystrophy Association

    collaborator OTHER
  • University of Rochester

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • King's College Hospital NHS Trust

    collaborator OTHER
  • Sydney Children's Hospitals Network

    collaborator OTHER
  • Children's Hospital of Philadelphia

    collaborator OTHER
  • University of Miami

    collaborator OTHER
  • Johns Hopkins University

    collaborator OTHER
  • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

    collaborator OTHER
  • Cedars-Sinai Medical Center

    collaborator OTHER
  • Nemours Children's Clinic

    collaborator OTHER
  • Stanford University

    collaborator OTHER
  • University of Minnesota

    collaborator OTHER
  • Massachusetts General Hospital

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • Children's National Research Institute

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • St. Jude Children's Research Hospital

    collaborator OTHER
  • Connecticut Children's Medical Center

    collaborator OTHER
  • Seattle Children's Hospital

    collaborator OTHER
  • The Hospital for Sick Children

    collaborator OTHER
  • University of Iowa

    lead OTHER

Principal Investigators

  • Michael E Shy, MD · University of Iowa

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States
  • Australia
  • Canada
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01193088 on ClinicalTrials.gov